Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 19, 2016
Endothelin research and the discovery of macitentan for the treatment of pulmonary arterial hypertensionMartine ClozelCanadian Journal of Physiology and Pharmacology|March 4, 2022
Aprocitentan and the endothelin system in resistant hypertensionMartine ClozelAnnals of Medicine|May 21, 2005
Role of endothelin in fibrosis and anti-fibrotic potential of bosentanMartine Clozel, Hashem SalloukhAdvances in Pharmacology (San Diego, Calif.)|November 18, 2010
The cardiovascular physiology and pharmacology of endothelin-1Eric Thorin, Martine ClozelCurrent Hypertension Reports|March 19, 2003
Role of endothelin-1 in hypertensionMarc Iglarz, Ernesto L SchiffrinHandbook of Experimental Pharmacology|October 5, 2013
Endothelin receptor antagonistsMartine Clozel, Alessandro Maresta, Marc HumbertThe Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonistMarc Iglarz, Christoph Binkert, Keith Morrison, et al.Journal of Medicinal Chemistry|August 7, 2012
The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonistMartin H Bolli, Christoph Boss, Christoph Binkert, et al.The Journal of Pharmacology and Experimental Therapeutics|January 10, 2019
Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental HypertensionFrederic Trensz, Céline Bortolamiol, Markus Kramberg, et al.Current Protocols in Pharmacology|February 2, 2012
Monocrotaline-induced pulmonary hypertension in Wistar ratsMarkus Rey, Patrick Hess, Martine ClozelPageof 10